Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Alberta

$27,000.00

Building Research Infrastructure to Define Global Endpoints in Pediatric Blood Pressure Trials (BRIDGE-BP)

EF 2025-26

Résumé
Early treatment of hypertension is crucial in preventing chronic consequences, however, there are limited head-to-head comparative trials of antihypertensive therapy that identify superior gold-standard medications. There are two methodological issues that must be addressed before a large, pragmatic, randomized pediatric hypertension trial can be developed: defining minimal clinically important differences (MCIDs) and establishing consensus on Desirability Of Outcome Ranking (DOOR). Building Research Infrastructure to Define Global Endpoints in Pediatric Blood Pressure Trials (BRIDGE-BP) will deliver the first international consensus on DOOR domains and MCIDs for pediatric blood pressure trials, which are currently needed endpoints around patient-centered research. By harmonizing clinical and patient priorities through a Delphi processes and collaborative workshops, the project will set a new methodological benchmark for pediatric hypertension research to be applied globally. The outputs will inform the design of the forthcoming Pediatric Antihypertensive Comparative Effectiveness for Blood Pressure Reduction (PACE-BP) randomized trial, ensuring it is powered to detect differences that are statistically robust and clinically meaningful. Outputs will inform sample size estimation, data harmonization, and interpretation of efficacy across future trials. This study will ensure meaningful engagement of underrepresented groups, including children and families from minoritized backgrounds disproportionately affected by hypertension. Beyond its objectives, this project will build a sustainable, international network that integrates patient partners, clinicians, and scientists across diverse settings, and strengthen Canada’s leadership in pediatric cardiovascular health.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573129
Name
Arvikar Eisha
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Building Research Infrastructure to Define Global Endpoints in Pediatric Blood Pressure Trials (BRIDGE-BP)
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cardiology; Clinical Trials; Community Engagement; Global Health; Health Promotion; Hypertension; Methodology; Nephrology; Pediatrics; Public Health
Abstract
Early treatment of hypertension is crucial in preventing chronic consequences, however, there are limited head-to-head comparative trials of antihypertensive therapy that identify superior gold-standard medications. There are two methodological issues that must be addressed before a large, pragmatic, randomized pediatric hypertension trial can be developed: defining minimal clinically important differences (MCIDs) and establishing consensus on Desirability Of Outcome Ranking (DOOR). Building Research Infrastructure to Define Global Endpoints in Pediatric Blood Pressure Trials (BRIDGE-BP) will deliver the first international consensus on DOOR domains and MCIDs for pediatric blood pressure trials, which are currently needed endpoints around patient-centered research. By harmonizing clinical and patient priorities through a Delphi processes and collaborative workshops, the project will set a new methodological benchmark for pediatric hypertension research to be applied globally. The outputs will inform the design of the forthcoming Pediatric Antihypertensive Comparative Effectiveness for Blood Pressure Reduction (PACE-BP) randomized trial, ensuring it is powered to detect differences that are statistically robust and clinically meaningful. Outputs will inform sample size estimation, data harmonization, and interpretation of efficacy across future trials. This study will ensure meaningful engagement of underrepresented groups, including children and families from minoritized backgrounds disproportionately affected by hypertension. Beyond its objectives, this project will build a sustainable, international network that integrates patient partners, clinicians, and scientists across diverse settings, and strengthen Canada’s leadership in pediatric cardiovascular health.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Arvikar, Eisha
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~